Enhanced Functionality of Anti-GPC3 CAR-T Cells Against Hepatocellular Carcinoma Through Locoregional Administration.

An observed trend of faster response (Figure 1E ) and a higher level of serum interferon‐gamma (IFN‐γ) detected at the endpoint in the i.t. group compared to the t.v. group (Figure 1F ) suggested the potential of locoregional administration to enhance the efficacy of CAR‐T cells in treating solid tumours. 2.2.

also in 257 other papers